Heparins Outperform DOACs and FXII/FXI Inhibitors in Preventing Thrombin Generation: JTH Study
Journal of Thrombosis and Haemostasis (JTH) shared an insightful post on LinkedIn:
“Effect of heparins, direct oral anticoagulants, and factor XII/factor XI inhibitors on catheter-initiated thrombin generation in platelet-rich plasma: an in vitro study
This in vitro catheter-initiated thrombin generation model compared heparins, DOACs, and emerging FXII/FXI inhibitors. Heparins were the most effective, with UFH completely suppressing thrombin generation at clinically relevant concentrations. DOACs and fondaparinux showed limited efficacy, while FXII/FXI inhibitors (asundexian, milvexian, garadacimab, abelacimab) did not adequately prevent coagulation on artificial surfaces. Results align with clinical observations, reinforcing UFH as the gold standard in invasive endovascular procedures.”
Read the full article here:
Article: Effect of heparins, direct oral anticoagulants, and factor XII/factor XI inhibitors on catheter-initiated thrombin generation in platelet-rich plasma: an in vitro study
Authors: Michael Hardy, Henri Thonon, Jonathan Douxfils, Julie Vassart, Isabelle Gouin–Thibault, Sarah Lessire, Thomas Lecompte, Francois
Stay updated with Hemostasis Today.
-
Apr 22, 2026, 07:56Shruti Kharat: Closing the Gap in Early Detection of Factor VIII Inhibitors
-
Apr 22, 2026, 07:46Gregory Piazza: Ushering in a New Era in PE Therapy and Improved Clinical Outcomes for Our Patients
-
Apr 22, 2026, 07:40Akshat Jain: WIL33 Study Advances Factor Prophylaxis in Children with von Willebrand Disease
-
Apr 22, 2026, 07:36Selma Turkovic: Blood Transfusion Education and Discussion Group Webinar 61
-
Apr 22, 2026, 07:34Aikati Anastasiou: Advancing Stroke Imaging Insights from the DISTAL Trial
-
Apr 22, 2026, 07:26Maxime Dely: How Do We Balance Benefit and Risk in Chronic Hematologic Diseases?
-
Apr 22, 2026, 07:19Sarah Richardson: Bringing Insights from HFA Symposium Back to Real Life
-
Apr 22, 2026, 07:17Karuna Kumar: Interesting Trial from Gambia on Treating Iron Deficiency in Children
-
Apr 22, 2026, 07:12Mary Catherine Moffett: Celebrating 32 Years of Patient-Centered Advocacy with the Hemophilia Federation of America